La Jolla Pharmaceutical Company

NasdaqCM:LJPC Stock Report

Market Cap: US$155.1m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

La Jolla Pharmaceutical Company Company Information

La Jolla Pharmaceutical Company's employee growth, exchange listings and data sources


Key Information

  • Name: La Jolla Pharmaceutical Company
  • Ticker: LJPC
  • Exchange: NasdaqCM
  • Founded: 1989
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$155.107m
  • Shares Outstanding: 24.94m
  • Website: https://www.lajollapharmaceutical.com

Number of Employees


Location

  • La Jolla Pharmaceutical Company
  • 201 Jones Road
  • Suite 400
  • Waltham
  • Massachusetts
  • 2451
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
LJPCNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJun 1994
LJPPDB (Deutsche Boerse AG)YesCommon StockDEEURJun 1994

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/08/22 09:29
End of Day Share Price 2022/08/19 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

La Jolla Pharmaceutical Company is covered by 11 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Keay NakaeChardan Capital Markets, LLC
Reni BenjaminH.C. Wainwright & Co.
Eun Kyung YangJefferies LLC